You are currently viewing Side branch occlusion in 500 ABSORB BVS Clinical implications and Solutions

Side branch occlusion in 500 ABSORB BVS Clinical implications and Solutions

EBC - ON DEMAND

Side branch occlusion in 500 ABSORB BVS Clinical implications and Solutions

European Bifurcation Club 2012 – EBC 2012 – Castelldefels, Spain

“News” session

Side branch occlusion in 500 ABSORB BVS Clinical implications and Solutions

Author: Robert-Jan van Geuns, MD, PhD, Associate Professor,Thoraxcenter, Erasmus Medical Center, Rotterdam, the Netherlands

 

BACKGROUND

  • Periprocedural myocardial infarction (MI) has been associated with unfavorable late clinical outcomes.1-3
  • Side branch occlusion contributes to the periprocedural MI.
  • Previous drug-eluting metallic stent studies suggest that the incidence of side branch occlusion is presumably attributable to the strut/polymer thickness and width.4,5
  • The incidence of side branch occlusion after bioresorbable scaffold implantation has been unexplored.

SUMMARY

  • Overall incidence rate of post-procedural side branch occlusion was 5.9% (66/1127).
  • BVS can be recrossed if necessary with small balloon
  • Kissing should be avoided, POT is possible

 

Download here

Leave a Reply